ReviewBritish journal of clinical pharmacology2015
The prevention and management of infections due to multidrug resistant organisms in haematology patients.
Review in British journal of clinical pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Trial
- Empiric antibiotic regimen for febrile neutropenia in cancer patients: a tertiary oncology center experience.Frontiers in oncology · 2026Article
- Preneutropenic Fever in Patients With Hematological Malignancies: A Novel Target for Antimicrobial Stewardship.Open forum infectious diseases · 2024Article
- Replicon-Based Typing About IncG Plasmids and Molecular Characterization of Five IncG Plasmids Carrying Carbapenem Resistance GeneInfection and drug resistance · 2024Article
- Low Motor Dexterity and Significant Behaviors Following Hospitalized Isolation in Children.Children (Basel, Switzerland) · 2023Article
- Evaluation of a Shotgun Metagenomics Approach for Detection of ESBL- and/or Carbapenemase-ProducingMicroorganisms · 2023Article
- Antimicrobial Stewardship Interventions in Pediatric Oncology: A Systematic Review.Journal of clinical medicine · 2022Review
- Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute.GMS hygiene and infection control · 2022Article
- Late effects of cancer in children, teenagers and young adults: Population-based study on the burden of 183 conditions, in-patient and critical care admissions and years of life lost.The Lancet regional health. Europe · 2022Article
- Article
- Infections Due to Carbapenem-Resistant Bacteria in Patients With Hematologic Malignancies.Frontiers in microbiology · 2020Review
- Genomic characterization ofAntimicrobial resistance and infection control · 2019Article
- Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer.The Journal of antimicrobial chemotherapy · 2018Article
- Update on infection control practices in cancer hospitals.CA: a cancer journal for clinicians · 2018Review
- Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions.Current oncology reports · 2017Review
- Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Mediterranean journal of hematology and infectious diseases · 2017Review
- Weekly screening supports terminating nosocomial transmissions of vancomycin-resistant enterococci on an oncologic ward - a retrospective analysis.Antimicrobial resistance and infection control · 2017Article
- The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies.Leukemia & lymphoma · 2016Review
- From an evolutionary perspective, all 'new' antimicrobial targets are old: time to think outside the box.British journal of clinical pharmacology · 2015Article
- The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients.Antimicrobial resistance and infection control · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infections due to resistant and multidrug resistant (MDR) organisms in haematology patients and haematopoietic stem cell transplant recipients are an increasingly complex problem of global concern. We outline the burden of illness and epidemiology of resistant organisms such as gram-negative pathogens, vancomycin-resistant Enterococcus faecium (VRE), and Clostridium difficile in haematology cohorts. Intervention strategies aimed at reducing the impact of these organisms are reviewed: infection prevention programmes, screening and fluoroquinolone prophylaxis. The role of newer therapies (e.g. linezolid, daptomycin and tigecycline) for treatment of resistant and MDR organisms in haematology populations is evaluated, in addition to the mobilization of older agents (e.g. colistin, pristinamycin and fosfomycin) and the potential benefit of combination regimens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.